Susie Nazzaro

Susan Nazzaro is an access to medicines expert with experience across the not-for-profit and private sectors. She is currently a director in the Global Access and Value team at Pfizer with responsibility for access and pricing strategy in the early oncology portfolio. Prior to Pfizer, she was a Director at Seagen, the industry leader in antibody-drug conjugates for treatment of cancer. There, she led the early pipeline access function, developing the company’s strategy to ensure pipeline medicines were developed to maximize rapid patient access. Previously, she led efforts to ensure access to essential health products for patients in low- and middle-income countries at the Bill and Melinda Gates Foundation, including all new product introduction for the malaria program. She led the launch of a comprehensive package of novel tools to treat p.vivax malaria as well as the transition of the sub-Saharan African market away from less effective insecticides to new long-lasting insecticide treated nets for the prevention of malaria.  She was also part of the team managing the foundation’s engagement with the Global Fund to Fight AIDS, TB, & Malaria for over a decade, serving as the Chief of Staff and Senior Advisor to the Vice-Chair of the Global Fund Board. She currently serves as an advisor to the Medicines for Malaria Venture and Evidence Action, two NGOs aiming to bring innovative medicines and health programs to low-income countries. She has also been a consultant at the World Bank and a Peace Corps volunteer in Madagascar.

She holds a B.A from Wellesley College and an M.Sc. in development economics from the London School of Economics. She lives in Seattle with her husband Cory and their two children Ozzy (11) and Vera (7). When not chasing her small people around, she can be found cheering for the Seattle Sounders and Tottenham Hotspur or spending too much money on records.